Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 0.19%, closing at 1007.53 points, with a total trading volume of 3.622 billion shares and a turnover of 124.775 billion yuan, resulting in an average turnover rate of 2.02% [1] - Among the tradable stocks on the STAR Market, 324 stocks closed higher, with 9 stocks experiencing a rise of over 10%, including Electric Wind Power, Fumiao Technology, and Shangwei New Materials, which hit the daily limit [1] - The distribution of turnover rates shows that 2 stocks had turnover rates exceeding 20%, 24 stocks had rates between 10% and 20%, and 59 stocks had rates between 5% and 10% [1] High Turnover Stocks - The stock with the highest turnover rate was Xinyuren, which closed up by 3.51% with a turnover rate of 23.24% and a transaction amount of 368 million yuan [3] - Other notable stocks included Aerospace Nanhu, which rose by 5.00% with a turnover rate of 20.06%, and Suochen Technology, which had a turnover rate of 19.66% [3] Sector Analysis - In terms of sector performance, the pharmaceutical and biotechnology sector had the most stocks with a turnover rate exceeding 5%, totaling 32 stocks, followed by the computer and electronics sectors with 18 and 7 stocks, respectively [2] - Among the high turnover stocks, 58 stocks rose today, with Fumiao Technology, Olin Biology, and DeMa Technology leading with increases of 20.02%, 18.93%, and 14.74%, respectively [2] Capital Flow - In terms of capital flow, 48 stocks with high turnover rates saw net inflows from main funds, with the highest net inflows recorded for Youkede, Kaiyin Technology, and Rongchang Biology, amounting to 104 million yuan, 9.403 million yuan, and 6.991 million yuan, respectively [2] - Conversely, the stocks with the largest net outflows included Guokexingong, Maiwei Biology, and Jiayuan Technology, with net outflows of 239 million yuan, 16.9 million yuan, and 13.4 million yuan, respectively [2] Leverage Fund Movements - A total of 51 stocks with high turnover rates recently received net purchases from leveraged funds, with notable increases in financing balances for Gaoce Shares, Shijia Photon, and Weixin Biology, which saw increases of 72.986 million yuan, 71.531 million yuan, and 71.373 million yuan, respectively [2]

Economic Growth and Consumption - Consumption has contributed approximately 60% to economic growth during the "14th Five-Year Plan" period, highlighting its role as a main engine for growth [1][3] - The total retail sales of consumer goods in China is expected to exceed 50 trillion yuan this year, reflecting strong domestic consumption [2][3] Trade Performance - China's goods trade scale remains the largest globally, with export and import market shares stable at over 14% and 10% respectively [5][6] - The service trade scale ranks second globally, surpassing 1 trillion USD for the first time last year [6] Foreign Investment - China has completed its foreign investment target of 700 billion USD six months ahead of schedule, with actual foreign investment reaching 708.73 billion USD by mid-2023 [8][9] - The negative list for foreign investment access continues to shrink, with all restrictions in the manufacturing sector eliminated [9] Consumption Structure and Innovation - Service consumption has seen rapid growth, with an average annual increase of 9.6% from 2020 to 2024 [3][4] - New consumption models, such as "artificial intelligence + consumption" and "IP + consumption," are emerging as new growth points [3][4] International Trade Relations - The diversification of trade partners is evident, with ASEAN being China's largest trading partner for five consecutive years [7] - The proportion of trade with countries involved in the Belt and Road Initiative is expected to exceed 50% by 2024 [7]

资金流向方面，科创板百元股今日主力资金合计净流出1.29亿元，净流入资金居前的有拓荆科技、寒武 纪、恒玄科技等，净流入资金分别为4556.25万元、3631.48万元、3030.31万元；净流出资金居前的有海 光信息、百济神州、金山办公等，净流出资金分别为15785.72万元、6653.65万元、3030.46万元。 融资融券方面，百元股最新（7月17日）融资余额合计258.11亿元，融资余额居前的有寒武纪、海光信 息、中微公司等，最新融资余额分别为37.12亿元、32.60亿元、27.76亿元。最新融券余额合计为1.63亿 元，融券余额居前的有海光信息、寒武纪、惠泰医疗等，最新融券余额分别为0.17亿元、0.12亿元、 0.12亿元。 以最新收盘价计算，科创板平均股价为31.78元，其中股价超100元的有41只，股价最高的是寒武纪。 证券时报·数据宝统计显示，科创板股今日上涨的有324只，下跌的有257只，以收盘价为基准测算，科 创板平均股价为31.78元，其中，收盘价超过100元的有41只，股价在50元至100元之间的有121只，股价 在30元至50元的有167只。 科创板股中，收盘价最高的是寒武纪，今日 ...

齐鲁晚报.齐鲁壹点马玉姝 4月22日，天津市药品监督管理局发布公告称，天津未名在GMP符合性检查中未达规范要求，被采取暂停生产、销售风险控制措 施。 7月4日，因实验进度未及预期，天津未名预计在三个月内无法恢复正常生产经营活动。这一核心生产主体的持续停摆，导致未 名医药于7月8日被深交所实施其他风险提示，股票名称变更为"ST未名（002581）"，股票交易涨跌幅限制由10%变为5%。 海岱财经梳理获知，天津未名生产、销售的人干扰素药品是支撑未名医药营收的主要来源。据财报显示，2024年，天津未名实 现营业收入2.16亿元，净利润-1400.37万元，分别占同期未名医药营业收入的60%，合并报表净利润的9.8%，对收入规模贡献最 大。 截至目前，淄博共有2家A股上市公司被实施其他风险警示(ST)。另一家山东联创产业发展集团股份有限公司(简称"联创股份")于 3月25日起被实施ST警示。 据联创股份最新业绩披露，公司一季度实现营业收入1.6亿元，同比增长12.20%；净利润从去年同期-1555.44万元增长至501.64万 元，同比增长132.25%。 资本市场的连锁反应仍在持续。 7月17日晚间，山东未名生物医 ...

证券代码:002880 证券简称:卫光生物 公告编号:2025-030 深圳市卫光生物制品股份有限公司 相关主体承诺的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 深圳市卫光生物制品股份有限公司（以下简称"公司"）于2025年7月17日 召开第四届董事会第一次会议，审议通过了《关于2025年度向特定对象发行A股 股票摊薄即期股东回报、填补措施及相关主体承诺的议案》。根据《国务院办公 厅关于进一步加强资本市场中小投资者合法权益保护工作的意见》（国办发 2013110号）、《国务院关于进一步促进资本市场健康发展的若干意见》（国发 201417号）及《关于首发及再融资、重大资产重组摊薄即期回报有关事项的指 导意见》（中国证券监督管理委员会公告201531号）的相关要求，为保障中小 投资者利益，公司就2025年度向特定对象发行A股股票（以下简称"本次发行"） 摊薄即期回报对公司主要财务指标的影响进行了分析，并提出了拟采取的填补回 报措施，相关主体对公司填补回报措施能够得到切实履行作出了承诺，具体情况 说明如下： 一、本次发行摊薄即期回报对公司主要财务指标的影响 ...

Core Viewpoint - The audit committee of Shenzhen Weiguang Biological Products Co., Ltd. has reviewed and approved the plan for the company to issue A-shares to specific targets in 2025, confirming compliance with relevant laws and regulations [2][3][4]. Compliance and Feasibility - The company meets the qualifications and conditions for issuing shares to specific targets as per the Company Law, Securities Law, and relevant regulations [2]. - The proposed issuance plan is deemed fair, reasonable, and feasible, aligning with the company's industry status, operational needs, and funding requirements [3]. Strategic Alignment - The issuance is expected to enhance the company's operational performance and aligns with its development strategy, benefiting all shareholders [3]. - The fundraising projects are closely related to the company's main business and comply with national industrial policies, promising good market prospects and economic benefits [4]. Financial Impact and Measures - The company has conducted a thorough analysis of the impact on immediate returns due to share dilution and has proposed specific measures to mitigate this effect, in line with regulatory requirements [4]. - The company has not raised funds through other means in the last five accounting years, thus exempting it from preparing a report on the use of previous fundraising [5]. Dividend Policy - The company has established a shareholder dividend return plan for 2025-2027, which supports sustainable development and aligns with legal and regulatory requirements [5]. Procedural Compliance - The preparation and review processes for the issuance documents comply with all relevant laws, regulations, and internal management systems, pending approval from the shareholders' meeting and regulatory bodies [5].

深圳市卫光生物制品股份有限公司 本项目由卫光生物实施，项目总投资 230,794.66 万元，其中拟以募集资金投 入 120,000.00 万元，本项目建设期为 4.5 年。 使用的可行性分析报告 二〇二五年七月 目 录 本可行性分析报告（以下简称"本报告"）中如无特别说明，相关用语具有 与《深圳市卫光生物制品股份有限公司 2025 年度向特定对象发行 A 股股票预案》 中相同的含义。 一、本次募集资金使用计划 公司本次向特定对象发行股票拟募集资金总额（含发行费用）为 15.00 亿元， 扣除发行费用后的募集资金净额将用于： | | | | 单位：万元 | | --- | --- | --- | --- | | 序号 | 项目名称 | 项目投资总额 | 拟使用募集资金 | | | 合计 | 260,794.66 | 150,000.00 | 本次向特定对象发行股票募集资金到位后，若实际募集资金数额（扣除发行 费用后）少于上述项目拟投入的募集资金总额，在最终确定的本次募投项目范围 内，公司将根据实际募集资金数额，按照项目的轻重缓急等情况，调整并最终决 定募集资金的具体投资项目、优先顺序及各项目的具体投资额，募集 ...

以最新收盘价计算，A股平均股价为12.12元，其中股价超过100元的有96只。 市场表现方面，收盘股价超百元股中，今日平均上涨0.55%，跑赢沪指0.04个百分点。今日上涨的有48 只，涨幅居前的有深信服、汇成真空等，下跌的有47只，跌幅居前的有春风动力、源杰科技等。 | 688608 | 恒玄科技 | 232.80 | 1.06 | 0.02 | 电子 | | --- | --- | --- | --- | --- | --- | | 688692 | 达梦数据 | 228.30 | 2.81 | 0.03 | 计算机 | | 300760 | 迈瑞医疗 | 225.32 | 3.75 | 0.93 | 医药生物 | | 603129 | 春风动力 | 214.13 | -7.46 | 2.93 | 汽车 | | 688498 | 源杰科技 | 208.00 | -6.73 | 0.05 | 电子 | | 300779 | 惠城环保 | 205.52 | -0.60 | 3.13 | 环保 | | 688279 | 峰岹科技 | 203.26 | -0.73 | 0.02 | 电子 | | 688068 | ...

Core Insights - The industrial added value of large-scale industries in China grew by 6.4% year-on-year in the first half of the year, demonstrating strong resilience following a good start in the first quarter [1] - The manufacturing added value accounted for 25.7% of GDP, remaining stable [1] - Key industries such as electrical machinery, automobiles, electronics, general equipment, chemicals, and non-ferrous metals showed rapid growth, contributing significantly to the overall industrial growth [1] Group 1: Industrial Performance - In the first quarter and second quarter, the industrial added value grew by 6.5% and 6.3% year-on-year, respectively, building on a high base from the previous year [1] - The contribution rates of equipment manufacturing and high-tech manufacturing increased, with their added values reaching 35.5% and 16.4% of large-scale industries, respectively [1] - Profits in industries such as electronics, electrical machinery, and general equipment grew by over 10% [1] Group 2: Regional Contributions - All 31 provinces reported growth in industrial added value, with provinces like Fujian, Anhui, Henan, and Hunan achieving over 8% growth [1] - Eight industrial provinces saw profit growth rates exceeding the national average, with Henan, Hunan, Hubei, and Jiangsu achieving double-digit growth [1] Group 3: Future Initiatives - The Ministry of Industry and Information Technology plans to implement a new round of growth stabilization work for ten key industries, including steel, non-ferrous metals, petrochemicals, and building materials [1] - Support will be provided to key industrial provinces to enhance their roles, including policy implementation, new growth point cultivation, and industrial transformation [1] - The ministry aims to accelerate the "Artificial Intelligence +" initiative, promoting the deployment of large models in key manufacturing sectors to enhance intelligence levels [1]

据日经新闻：Moderna(MRNA.O)因需求疲软取消了在日本的mRNA工厂计划。 ...